OTCMKTS:IVITF - Invictus MD Strategies Stock Price, News & Analysis

$0.1756
-0.02 (-8.87 %)
(As of 09/18/2019 08:00 AM ET)
Today's Range
$0.1675
Now: $0.1756
$0.1898
50-Day Range
$0.1763
MA: $0.24
$0.2899
52-Week Range
$0.1675
Now: $0.1756
$1.81
Volume153,491 shs
Average Volume161,721 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Invictus MD Strategies Corp. and its subsidiaries primarily engage in the investment, acquisition, and development of synergistic businesses in the medical cannabis industry in Canada. It produces and sells medical cannabis; plant fertilizers, nutrients, and other supplies for hydroponics; and develops technology to vaporize cannabis. The company was incorporated in 2014 and is headquartered in White Rock, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:IVITF
CUSIPN/A
CIKN/A
Phone844-800-6086

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive IVITF News and Ratings via Email

Sign-up to receive the latest news and ratings for IVITF and its competitors with MarketBeat's FREE daily newsletter.


Invictus MD Strategies (OTCMKTS:IVITF) Frequently Asked Questions

What is Invictus MD Strategies' stock symbol?

Invictus MD Strategies trades on the OTCMKTS under the ticker symbol "IVITF."

Has Invictus MD Strategies been receiving favorable news coverage?

Press coverage about IVITF stock has trended negative recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Invictus MD Strategies earned a coverage optimism score of -2.9 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Invictus MD Strategies.

Who are some of Invictus MD Strategies' key competitors?

What other stocks do shareholders of Invictus MD Strategies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invictus MD Strategies investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), SenesTech (SNES), OvaScience (OVAS), Opko Health (OPK), OrganiGram (OGI), HEXO (HEXO), Genetic Technologies (GENE), Ekso Bionics (EKSO) and Advanced Micro Devices (AMD).

Who are Invictus MD Strategies' key executives?

Invictus MD Strategies' management team includes the folowing people:
  • Mr. George Edward Kveton, CEO, Pres & Director
  • Mr. Daniel Stanislav Kriznic, Founder, Director and Advisor to Chairman & CEO (Age 40)
  • Ms. Harbir Toor, Chief Financial Officer
  • Brenda Dixon, Chief Science Officer
  • Mr. Larry Heinzlmeir MBA, VP of Marketing & Communications

How do I buy shares of Invictus MD Strategies?

Shares of IVITF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Invictus MD Strategies' stock price today?

One share of IVITF stock can currently be purchased for approximately $0.1756.

What is Invictus MD Strategies' official website?

The official website for Invictus MD Strategies is http://invictus-md.com/.

How can I contact Invictus MD Strategies?

The company can be reached via phone at 844-800-6086.


MarketBeat Community Rating for Invictus MD Strategies (OTCMKTS IVITF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  5 (Vote Outperform)
Underperform Votes:  5 (Vote Underperform)
Total Votes:  10
MarketBeat's community ratings are surveys of what our community members think about Invictus MD Strategies and other stocks. Vote "Outperform" if you believe IVITF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVITF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel